• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国农村地区结核病患者诊断和治疗经济负担分析。

Analysis of the economic burden of diagnosis and treatment of tuberculosis patients in rural China.

机构信息

Department of Tuberculosis, Third Hospital of Zhenjiang City, Zhenjiang, People's Republic of China; Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, People's Republic of China.

出版信息

Int J Tuberc Lung Dis. 2013 Dec;17(12):1575-80. doi: 10.5588/ijtld.13.0144.

DOI:10.5588/ijtld.13.0144
PMID:24200271
Abstract

SETTING

A county in Jiangsu Province, China.

OBJECTIVES

To estimate the costs of the diagnosis and treatment of tuberculosis (TB) from the patient's perspective and to identify determinants of the patient's financial burden.

DESIGN

In a cross-sectional survey, we interviewed 316 patients diagnosed from January 2010 to May 2011 who had already completed their anti-tuberculosis treatment. The financial burden on TB patients included out-of-pocket costs and productivity losses.

RESULTS

The average per capita total out-of-pocket cost was 3024.0 Chinese yuan (CNY), with a median cost of 1086 CNY (interquartile range [IQR] 480-2456). Mean out-of-pocket medical and non-medical costs were respectively 2565.7 CNY and 458.3 CNY. Productivity lost by patients and family members was 2615.2 CNY (median 500, IQR 250-2025). Factors associated with out-of-pocket costs and productivity losses included hospitalisation, adverse drug reactions, cost of drugs to 'protect' the liver, cost of second-line anti-tuberculosis drugs and diagnostic delay.

CONCLUSION

Although the government of China has implemented a 'free TB service policy', the economic burden on patients is still heavy. More patient-centred interventions are essential to reduce the financial burden on patients.

摘要

背景

中国江苏省某县。

目的

从患者角度估算结核病(TB)的诊断和治疗费用,并确定患者经济负担的决定因素。

设计

在一项横断面调查中,我们采访了 316 名 2010 年 1 月至 2011 年 5 月间已完成抗结核治疗的确诊患者。TB 患者的经济负担包括自付费用和生产力损失。

结果

人均总自付费用平均为 3024.0 元人民币(CNY),中位数为 1086 CNY(四分位距[IQR] 480-2456)。自付医疗和非医疗费用的平均值分别为 2565.7 CNY 和 458.3 CNY。患者和家属的生产力损失为 2615.2 CNY(中位数 500,IQR 250-2025)。与自付费用和生产力损失相关的因素包括住院、药物不良反应、护肝药物费用、二线抗结核药物费用和诊断延迟。

结论

尽管中国政府实施了“免费结核病服务政策”,但患者的经济负担仍然沉重。需要采取更多以患者为中心的干预措施,以减轻患者的经济负担。

相似文献

1
Analysis of the economic burden of diagnosis and treatment of tuberculosis patients in rural China.中国农村地区结核病患者诊断和治疗经济负担分析。
Int J Tuberc Lung Dis. 2013 Dec;17(12):1575-80. doi: 10.5588/ijtld.13.0144.
2
Free tuberculosis diagnosis and treatment are not enough: patient cost evidence from three continents.免费的结核病诊断和治疗还不够:来自三大洲的患者费用证据。
Int J Tuberc Lung Dis. 2013 Mar;17(3):381-7. doi: 10.5588/ijtld.12.0368.
3
Direct costs of pulmonary tuberculosis among patients receiving treatment in Bauchi State, Nigeria.尼日利亚包奇州接受治疗的肺结核患者的直接费用。
Int J Tuberc Lung Dis. 2012 Jun;16(6):835-40. doi: 10.5588/ijtld.10.0774.
4
How affordable are tuberculosis diagnosis and treatment in rural China? An analysis from community and tuberculosis patient perspectives.中国农村地区的结核病诊断和治疗费用可承受性如何?基于社区和结核病患者视角的分析。
Trop Med Int Health. 2007 Dec;12(12):1464-71. doi: 10.1111/j.1365-3156.2007.01953.x.
5
Is tuberculosis treatment really free in China? A study comparing two areas with different management models.在中国,结核病治疗真的免费吗?一项比较两种不同管理模式地区的研究。
PLoS One. 2015 May 20;10(5):e0126770. doi: 10.1371/journal.pone.0126770. eCollection 2015.
6
Socio-economic factors affecting the success of tuberculosis treatment in six counties of Shandong Province, China.社会经济因素对中国山东省六个县结核病治疗效果的影响。
Int J Tuberc Lung Dis. 2010 Apr;14(4):440-6.
7
Tuberculosis patient expenditure on drugs and tests in subsidised, public services in China: a descriptive study.中国结核病患者在补贴的公共卫生服务中药物和检测支出:描述性研究。
Trop Med Int Health. 2010 Jan;15(1):26-32. doi: 10.1111/j.1365-3156.2009.02427.x. Epub 2009 Nov 16.
8
Economic burden of schizophrenia: empirical analyses from a survey in Thailand.精神分裂症的经济负担:来自泰国一项调查的实证分析。
J Ment Health Policy Econ. 2012 Mar;15(1):25-32.
9
Tuberculosis care strategies and their economic consequences for patients: the missing link to end tuberculosis.结核病护理策略及其对患者的经济影响:终结结核病的缺失环节。
Infect Dis Poverty. 2016 Nov 1;5(1):93. doi: 10.1186/s40249-016-0187-9.
10
Factors that associated with TB patient admission rate and TB inpatient service cost: a cross-sectional study in China.与结核病患者入院率和结核病住院服务成本相关的因素:中国的一项横断面研究
Infect Dis Poverty. 2016 Jan 20;5:4. doi: 10.1186/s40249-016-0097-x.

引用本文的文献

1
Unit costs and cost-effectiveness of a device to improve TB treatment adherence in China.中国一种提高结核病治疗依从性的设备的单位成本和成本效益
IJTLD Open. 2024 Jul 1;1(7):299-305. doi: 10.5588/ijtldopen.23.0451. eCollection 2024 Jul.
2
Community-based directly observed therapy is effective and results in better treatment outcomes for patients with multi-drug resistant tuberculosis in Uganda.在乌干达,以社区为基础的直接观察治疗对耐多药结核病患者有效,并可改善治疗结果。
BMC Health Serv Res. 2023 Nov 13;23(1):1248. doi: 10.1186/s12913-023-10120-7.
3
Impacts of Medical Security Level on Treatment Outcomes of Drug-Resistant Tuberculosis: Evidence from Wuhan City, China.
医疗保障水平对耐多药结核病治疗效果的影响:来自中国武汉市的证据
Patient Prefer Adherence. 2022 Dec 20;16:3341-3355. doi: 10.2147/PPA.S389231. eCollection 2022.
4
Estimating the pre- and post-diagnosis costs of tuberculosis for adults in Pakistan: household economic impact and costs mitigating strategies.估算巴基斯坦成人结核病的诊断前和诊断后成本:家庭经济影响和成本缓解策略。
Glob Health Res Policy. 2022 Jul 21;7(1):22. doi: 10.1186/s41256-022-00259-x.
5
Developing a patient-centered community-based model for management of multi-drug resistant tuberculosis in Uganda: a discrete choice experiment.在乌干达开发以患者为中心的社区为基础的耐多药结核病管理模式:离散选择实验。
BMC Health Serv Res. 2022 Feb 5;22(1):154. doi: 10.1186/s12913-021-07365-5.
6
The impact of ethnic minority status on tuberculosis diagnosis and treatment delays in Hunan Province, China.少数民族身份对中国湖南省结核病诊断和治疗延迟的影响。
BMC Infect Dis. 2022 Jan 26;22(1):90. doi: 10.1186/s12879-022-07072-4.
7
How to Effectively Identify Patients With Rifampin-Resistant Tuberculosis in China: Perspectives of Stakeholders Among Service Providers.如何在中国有效识别利福平耐药结核病患者:服务提供者利益相关者的观点。
Front Public Health. 2021 Nov 24;9:736632. doi: 10.3389/fpubh.2021.736632. eCollection 2021.
8
Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis.120 个国家结核病死亡的经济影响,以及未能实现可持续发展目标结核病具体目标的代价:全收入分析。
Lancet Glob Health. 2021 Oct;9(10):e1372-e1379. doi: 10.1016/S2214-109X(21)00299-0. Epub 2021 Sep 3.
9
Impacts of a comprehensive tuberculosis control model on the quality of clinical services and the financial burden of treatment for patients with drug-resistant tuberculosis in China: a mixed-methods evaluation.中国综合结核病控制模式对耐多药结核病患者临床服务质量和治疗经济负担的影响:混合方法评价。
Infect Dis Poverty. 2021 Apr 21;10(1):54. doi: 10.1186/s40249-021-00832-5.
10
Policy changes and the screening, diagnosis and treatment of drug-resistant tuberculosis patients from 2015 to 2018 in Zhejiang Province, China: a retrospective cohort study.中国浙江省2015年至2018年耐药结核病患者的政策变化及筛查、诊断与治疗:一项回顾性队列研究
BMJ Open. 2021 Apr 12;11(4):e047023. doi: 10.1136/bmjopen-2020-047023.